CN102911911A - 人胚肾细胞293t-c10单克隆细胞株及其制备和应用 - Google Patents
人胚肾细胞293t-c10单克隆细胞株及其制备和应用 Download PDFInfo
- Publication number
- CN102911911A CN102911911A CN2012103783466A CN201210378346A CN102911911A CN 102911911 A CN102911911 A CN 102911911A CN 2012103783466 A CN2012103783466 A CN 2012103783466A CN 201210378346 A CN201210378346 A CN 201210378346A CN 102911911 A CN102911911 A CN 102911911A
- Authority
- CN
- China
- Prior art keywords
- cell
- monoclonal
- strain
- virus
- hekc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004027 cell Anatomy 0.000 title claims abstract description 162
- 238000002360 preparation method Methods 0.000 title claims description 7
- 210000003292 kidney cell Anatomy 0.000 title abstract 2
- 210000001161 mammalian embryo Anatomy 0.000 title abstract 2
- 241000700605 Viruses Species 0.000 claims abstract description 54
- 238000001890 transfection Methods 0.000 claims abstract description 47
- 238000012216 screening Methods 0.000 claims abstract description 21
- 238000000034 method Methods 0.000 claims abstract description 12
- 238000004806 packaging method and process Methods 0.000 claims abstract description 9
- 238000012856 packing Methods 0.000 claims description 21
- 241000204031 Mycoplasma Species 0.000 claims description 17
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 16
- 229910052791 calcium Inorganic materials 0.000 claims description 16
- 239000011575 calcium Substances 0.000 claims description 16
- 231100000331 toxic Toxicity 0.000 claims description 13
- 230000002588 toxic effect Effects 0.000 claims description 13
- 230000009385 viral infection Effects 0.000 claims description 6
- 210000004881 tumor cell Anatomy 0.000 claims description 5
- 238000012258 culturing Methods 0.000 claims description 4
- 231100000135 cytotoxicity Toxicity 0.000 claims description 4
- 230000003013 cytotoxicity Effects 0.000 claims description 4
- 238000010790 dilution Methods 0.000 claims description 4
- 239000012895 dilution Substances 0.000 claims description 4
- 238000004115 adherent culture Methods 0.000 claims description 2
- 206010028980 Neoplasm Diseases 0.000 abstract description 7
- 238000005199 ultracentrifugation Methods 0.000 abstract description 6
- 230000012010 growth Effects 0.000 abstract description 2
- 241001430197 Mollicutes Species 0.000 abstract 1
- 239000013612 plasmid Substances 0.000 description 20
- 208000015181 infectious disease Diseases 0.000 description 14
- 230000003612 virological effect Effects 0.000 description 14
- 238000002474 experimental method Methods 0.000 description 9
- 238000011084 recovery Methods 0.000 description 8
- 108020004414 DNA Proteins 0.000 description 7
- 210000001728 clone cell Anatomy 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 238000001514 detection method Methods 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 101000987295 Homo sapiens Serine/threonine-protein kinase PAK 5 Proteins 0.000 description 4
- 241000204003 Mycoplasmatales Species 0.000 description 4
- 230000001413 cellular effect Effects 0.000 description 4
- 238000011109 contamination Methods 0.000 description 4
- 239000000287 crude extract Substances 0.000 description 4
- 238000004113 cell culture Methods 0.000 description 3
- 230000010261 cell growth Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000004321 preservation Methods 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 102000003886 Glycoproteins Human genes 0.000 description 2
- 108090000288 Glycoproteins Proteins 0.000 description 2
- 101000825632 Homo sapiens Spindle and kinetochore-associated protein 1 Proteins 0.000 description 2
- 241000204028 Mycoplasma arginini Species 0.000 description 2
- 241000202938 Mycoplasma hyorhinis Species 0.000 description 2
- 241000202894 Mycoplasma orale Species 0.000 description 2
- 102100027941 Serine/threonine-protein kinase PAK 5 Human genes 0.000 description 2
- 102100022915 Spindle and kinetochore-associated protein 1 Human genes 0.000 description 2
- 101150063416 add gene Proteins 0.000 description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 235000011010 calcium phosphates Nutrition 0.000 description 2
- 230000003915 cell function Effects 0.000 description 2
- 239000012228 culture supernatant Substances 0.000 description 2
- 231100000433 cytotoxic Toxicity 0.000 description 2
- 230000001472 cytotoxic effect Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000010494 dissociation reaction Methods 0.000 description 2
- 230000005593 dissociations Effects 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 201000008968 osteosarcoma Diseases 0.000 description 2
- 239000013600 plasmid vector Substances 0.000 description 2
- 101150080685 ska1 gene Proteins 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- 239000013598 vector Substances 0.000 description 2
- 241000203024 Acholeplasma Species 0.000 description 1
- 241000203022 Acholeplasma laidlawii Species 0.000 description 1
- 229940123373 Adenovirus E1A gene Drugs 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 206010061598 Immunodeficiency Diseases 0.000 description 1
- 208000029462 Immunodeficiency disease Diseases 0.000 description 1
- 101710128836 Large T antigen Proteins 0.000 description 1
- 206010028470 Mycoplasma infections Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000004691 chief cell of stomach Anatomy 0.000 description 1
- 230000024835 cytogamy Effects 0.000 description 1
- 230000002380 cytological effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000004408 hybridoma Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000007813 immunodeficiency Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000012716 precipitator Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 201000007094 prostatitis Diseases 0.000 description 1
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical class C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000003146 transient transfection Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 210000002845 virion Anatomy 0.000 description 1
Images
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210378346.6A CN102911911B (zh) | 2012-09-29 | 2012-09-29 | 人胚肾细胞293t-c10单克隆细胞株及其制备和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210378346.6A CN102911911B (zh) | 2012-09-29 | 2012-09-29 | 人胚肾细胞293t-c10单克隆细胞株及其制备和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102911911A true CN102911911A (zh) | 2013-02-06 |
CN102911911B CN102911911B (zh) | 2014-11-26 |
Family
ID=47610492
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210378346.6A Expired - Fee Related CN102911911B (zh) | 2012-09-29 | 2012-09-29 | 人胚肾细胞293t-c10单克隆细胞株及其制备和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102911911B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104988114A (zh) * | 2015-07-10 | 2015-10-21 | 上海吉凯基因化学技术有限公司 | 一种稳定高效包装病毒的293t 细胞株及其应用 |
CN111154713A (zh) * | 2020-01-17 | 2020-05-15 | 郑州大学 | 人胚肾上皮细胞293T-Clone3单克隆细胞株及其应用 |
CN114807047A (zh) * | 2022-04-28 | 2022-07-29 | 中山康天晟合生物技术有限公司 | 一种高表达病毒的人胚胎肾细胞293及其用途 |
CN115873787A (zh) * | 2022-12-28 | 2023-03-31 | 云舟生物科技(广州)股份有限公司 | 一种高效转染细胞株及其制备方法和应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1513985A (zh) * | 2003-06-13 | 2004-07-21 | 张晓志 | 人胚肾293细胞亚克隆细胞株 |
-
2012
- 2012-09-29 CN CN201210378346.6A patent/CN102911911B/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1513985A (zh) * | 2003-06-13 | 2004-07-21 | 张晓志 | 人胚肾293细胞亚克隆细胞株 |
Non-Patent Citations (5)
Title |
---|
CLONTECH: "Lenti-X™ 293T Cells for Superior Lentivirus Packaging", 《CLONTECHNIQUES》 * |
CLONTECH: "Lenti-X™ 293T Cells for Superior Lentivirus Packaging", 《CLONTECHNIQUES》, 31 October 2008 (2008-10-31), pages 1 * |
周饮想等: "支原体污染对重组逆转录病毒的产生和感染靶细胞的影响", 《上海交通大学学报(医学版)》 * |
唐蓓: "一种稳定且高效的磷酸钙293T细胞转染法", 《生物技术》 * |
孙克宁等: "贴壁和悬浮状态293T 细胞慢病毒包装效果的比较研究", 《河南农业大学学报》 * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104988114A (zh) * | 2015-07-10 | 2015-10-21 | 上海吉凯基因化学技术有限公司 | 一种稳定高效包装病毒的293t 细胞株及其应用 |
CN104988114B (zh) * | 2015-07-10 | 2018-10-09 | 上海吉凯基因化学技术有限公司 | 一种稳定高效包装病毒的293t细胞株及其应用 |
CN111154713A (zh) * | 2020-01-17 | 2020-05-15 | 郑州大学 | 人胚肾上皮细胞293T-Clone3单克隆细胞株及其应用 |
CN111154713B (zh) * | 2020-01-17 | 2022-03-25 | 郑州大学 | 人胚肾上皮细胞293T-Clone3单克隆细胞株及其应用 |
CN114807047A (zh) * | 2022-04-28 | 2022-07-29 | 中山康天晟合生物技术有限公司 | 一种高表达病毒的人胚胎肾细胞293及其用途 |
CN114807047B (zh) * | 2022-04-28 | 2022-11-15 | 中山康天晟合生物技术有限公司 | 一种高表达病毒的人胚胎肾细胞293及其用途 |
CN115873787A (zh) * | 2022-12-28 | 2023-03-31 | 云舟生物科技(广州)股份有限公司 | 一种高效转染细胞株及其制备方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
CN102911911B (zh) | 2014-11-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107557390A (zh) | 一种筛选cho细胞系高表达位点的方法 | |
US9598671B2 (en) | Cyprinid herpesvirus II-sensitive brain tissue cell line of Carassius auratus gibelio and establishing method and use thereof | |
CN102911911B (zh) | 人胚肾细胞293t-c10单克隆细胞株及其制备和应用 | |
CN113981007B (zh) | 基于hek293t克隆筛选的用于高滴度慢病毒生产的悬浮驯化方法 | |
CN103981153B (zh) | 伪狂犬病病毒双荧光标记缺失病毒的构建 | |
CN111073856A (zh) | 一种滋养细胞及其制备方法和在nk细胞扩增中的应用 | |
CN102807970A (zh) | 犬瘟热病毒敏感细胞系及其建立方法和应用 | |
CN105002097A (zh) | 一种大丽轮枝菌的单孢分离纯化方法 | |
CN104911152B (zh) | 一株重组传染性造血器官坏死病毒rIHNV HLJ‑09株及其构建方法和应用 | |
CN107794244A (zh) | Vero‑pAPN细胞系及其制备方法 | |
CN106222131B (zh) | 一种羔羊睾丸支持细胞自然传代细胞系及其在羊痘病毒分离培养和增殖中的用途 | |
Uchida et al. | Transformation of mouse 3T3 cells by T antigen-forming defective SV40 virions (T particles) | |
CN106754724A (zh) | 一种永生化的牛精原干细胞系及其构建方法 | |
CN103937748B (zh) | 可稳定表达人tmprss2蛋白的单细胞自悬浮生长mdck细胞株及其构建方法与应用 | |
CN104894054A (zh) | 一种猴胚胎肾上皮细胞Marc-145悬浮适应株及其在培养蓝耳病病毒、生产蓝耳病毒疫苗中的应用 | |
CN107236763A (zh) | 一种基于流式细胞术的构建基因敲除细胞系的方法 | |
CN103609331A (zh) | 利用交配型对蛹虫草菌株复壮和提高子实体产量的方法 | |
CN103525766A (zh) | 一种猪肾细胞系及其应用 | |
CN102911920A (zh) | Ⅱ型登革病毒kmb17细胞适应株及其制备方法 | |
CN116515728A (zh) | 无弹状病毒的Sf9-PT细胞及其应用 | |
Jarrett et al. | Restricted host range of a feline leukaemia virus | |
CN104988114B (zh) | 一种稳定高效包装病毒的293t细胞株及其应用 | |
CN103667170A (zh) | 一种制备中国被毛孢成熟分生孢子的方法 | |
RU2009137571A (ru) | Способ наращивания рекомбинантного аденовируса человека | |
CN105154390A (zh) | 重组腺病毒疫苗株高适应性hek293克隆细胞株及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: LAO XINYUAN Free format text: FORMER OWNER: SHANGHAI HUANGLI BIOTECHNOLOGY CO., LTD. Effective date: 20141008 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 200233 XUHUI, SHANGHAI TO: 200070 ZHABEI, SHANGHAI |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20141008 Address after: 200070 room 5, No. 12, Lane 401, Chen Jia Zhai Road, Shanghai, Zhabei District Applicant after: Lao Cuanyuan Address before: 200233, room 6, building 333, 306 Guiping Road, Shanghai, Xuhui District Applicant before: Shanghai Huangli Bio-Technology Co., Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SHANGHAI PUSHENG BIO-TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: LAO XINYUAN Effective date: 20150203 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 200070 ZHABEI, SHANGHAI TO: 201109 MINHANG, SHANGHAI |
|
TR01 | Transfer of patent right |
Effective date of registration: 20150203 Address after: 201109, Minhang District, Shanghai Road, No. 2, 1509, 1, G2 District Patentee after: Shanghai Pu Biotechnology Co. Ltd. Address before: 200070 room 5, No. 12, Lane 401, Chen Jia Zhai Road, Shanghai, Zhabei District Patentee before: Lao Cuanyuan |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20141126 Termination date: 20180929 |